Financhill
Sell
48

AXGN Quote, Financials, Valuation and Earnings

Last price:
$15.62
Seasonality move :
6.77%
Day range:
$14.54 - $15.89
52-week range:
$5.55 - $15.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.76x
P/B ratio:
6.92x
Volume:
1.1M
Avg. volume:
297.4K
1-year change:
124.96%
Market cap:
$688.1M
Revenue:
$159M
EPS (TTM):
-$0.32
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $106.7M $112.3M $127.4M $138.6M $159M
Revenue Growth (YoY) 27.13% 5.24% 13.41% 8.82% 14.74%
 
Cost of Revenues $17.3M $21.6M $22.9M $24.1M $31.1M
Gross Profit $89.4M $90.7M $104.4M $114.4M $127.9M
Gross Profit Margin 83.74% 80.78% 82% 82.58% 80.42%
 
R&D Expenses $17.5M $17.8M $24.2M $27.2M $28.3M
Selling, General & Admin $103.3M $96.1M $105.7M $117M $121M
Other Inc / (Exp) $2.3M $450K -$213K $1.4M $2.6M
Operating Expenses $120.8M $113.9M $129.8M $144.1M $149.3M
Operating Income -$31.4M -$23.2M -$25.4M -$29.7M -$21.5M
 
Net Interest Expenses $40K $1.1M $1.4M $624K $2.8M
EBT. Incl. Unusual Items -$29.1M -$23.8M -$27M -$28.9M -$21.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$29.1M -$23.8M -$27M -$28.9M -$21.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$29.1M -$23.8M -$27M -$28.9M -$21.7M
 
Basic EPS (Cont. Ops) -$0.74 -$0.60 -$0.65 -$0.69 -$0.51
Diluted EPS (Cont. Ops) -$0.74 -$0.60 -$0.65 -$0.69 -$0.51
Weighted Average Basic Share $39.2M $40M $41.2M $42.1M $42.9M
Weighted Average Diluted Share $39.2M $40M $41.2M $42.1M $42.9M
 
EBITDA -$26.2M -$19.3M -$20.9M -$23.5M -$13.3M
EBIT -$29.1M -$22.7M -$25.6M -$28.3M -$18.9M
 
Revenue (Reported) $106.7M $112.3M $127.4M $138.6M $159M
Operating Income (Reported) -$31.4M -$23.2M -$25.4M -$29.7M -$21.5M
Operating Income (Adjusted) -$29.1M -$22.7M -$25.6M -$28.3M -$18.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $33.4M $31.2M $37M $41.3M $48.6M
Revenue Growth (YoY) 17.03% -6.65% 18.44% 11.67% 17.87%
 
Cost of Revenues $5.7M $5.2M $6.2M $9.6M $12.2M
Gross Profit $27.7M $26M $30.8M $31.7M $36.4M
Gross Profit Margin 82.96% 83.21% 83.29% 76.82% 74.91%
 
R&D Expenses $4.2M $6.4M $7.1M $6.7M $7M
Selling, General & Admin $24.5M $26.3M $28.6M $29M $29.8M
Other Inc / (Exp) -$37K -$35K $598K $763K $351K
Operating Expenses $28.8M $32.7M $35.6M $35.7M $36.8M
Operating Income -$1M -$6.7M -$4.9M -$4M -$316K
 
Net Interest Expenses $397K $417K $61K $827K $1.9M
EBT. Incl. Unusual Items -$1.5M -$7.1M -$4.3M -$4.1M -$1.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$1.5M -$7.1M -$4.3M -$4.1M -$1.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1.5M -$7.1M -$4.3M -$4.1M -$1.9M
 
Basic EPS (Cont. Ops) -$0.04 -$0.17 -$0.10 -$0.10 -$0.04
Diluted EPS (Cont. Ops) -$0.04 -$0.17 -$0.10 -$0.10 -$0.04
Weighted Average Basic Share $40.1M $41.5M $42.2M $43M $43.9M
Weighted Average Diluted Share $40.1M $41.5M $42.2M $43M $43.9M
 
EBITDA -$188K -$5.6M -$3M -$1.9M $2M
EBIT -$1.1M -$6.7M -$4.3M -$3.3M $35K
 
Revenue (Reported) $33.4M $31.2M $37M $41.3M $48.6M
Operating Income (Reported) -$1M -$6.7M -$4.9M -$4M -$316K
Operating Income (Adjusted) -$1.1M -$6.7M -$4.3M -$3.3M $35K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $108M $128.3M $134M $152.3M $180.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $21M $23M $23.4M $32.4M $38.4M
Gross Profit $87M $105.4M $110.5M $119.9M $142.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $17.8M $22.8M $26.6M $27M $29.2M
Selling, General & Admin $94.4M $108M $113.3M $116.8M $121.7M
Other Inc / (Exp) $880K -$251K $1.2M $1.6M $2.4M
Operating Expenses $112.2M $130.8M $140M $143.7M $150.9M
Operating Income -$25.2M -$25.4M -$29.5M -$23.9M -$8.5M
 
Net Interest Expenses $467K $2M $593K $951K $8.2M
EBT. Incl. Unusual Items -$24.8M -$27.7M -$28.8M -$23.2M -$14.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$24.8M -$27.7M -$28.8M -$23.2M -$14.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$24.8M -$27.7M -$28.8M -$23.2M -$14.3M
 
Basic EPS (Cont. Ops) -$0.63 -$0.67 -$0.67 -$0.56 -$0.32
Diluted EPS (Cont. Ops) -$0.63 -$0.67 -$0.67 -$0.56 -$0.32
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$21.2M -$21M -$23.4M -$17.4M $1.7M
EBIT -$24.3M -$25.7M -$28.2M -$22.3M -$6.1M
 
Revenue (Reported) $108M $128.3M $134M $152.3M $180.9M
Operating Income (Reported) -$25.2M -$25.4M -$29.5M -$23.9M -$8.5M
Operating Income (Adjusted) -$24.3M -$25.7M -$28.2M -$22.3M -$6.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $79.8M $95.8M $102.4M $116.1M $137.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $16.1M $17.5M $18M $26.2M $33.5M
Gross Profit $63.7M $78.3M $84.4M $89.8M $104.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $12.9M $17.9M $20.3M $20.2M $21.1M
Selling, General & Admin $68.6M $80.5M $88.2M $88M $88.6M
Other Inc / (Exp) $491K -$210K $1.2M $1.4M $1.3M
Operating Expenses $81.5M $98.4M $108.5M $108.1M $109.7M
Operating Income -$17.8M -$20.1M -$24.1M -$18.3M -$5.3M
 
Net Interest Expenses $459K $1.4M $664K $991K $6.4M
EBT. Incl. Unusual Items -$17.8M -$21.7M -$23.5M -$17.8M -$10.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$17.8M -$21.7M -$23.5M -$17.8M -$10.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$17.8M -$21.7M -$23.5M -$17.8M -$10.4M
 
Basic EPS (Cont. Ops) -$0.45 -$0.52 -$0.55 -$0.43 -$0.23
Diluted EPS (Cont. Ops) -$0.45 -$0.52 -$0.55 -$0.43 -$0.23
Weighted Average Basic Share $119.6M $123.3M $126M $128.5M $130.8M
Weighted Average Diluted Share $119.6M $123.3M $126M $128.5M $130.8M
 
EBITDA -$14.9M -$16.6M -$19.2M -$13.1M $1.9M
EBIT -$17.3M -$20.3M -$22.9M -$16.8M -$4M
 
Revenue (Reported) $79.8M $95.8M $102.4M $116.1M $137.9M
Operating Income (Reported) -$17.8M -$20.1M -$24.1M -$18.3M -$5.3M
Operating Income (Adjusted) -$17.3M -$20.3M -$22.9M -$16.8M -$4M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $35.7M $48.8M $32.8M $15.3M $31M
Short Term Investments $60.8M $55.2M $51.3M $33.5M --
Accounts Receivable, Net $16.9M $17.6M $18.2M $22.2M $25.1M
Inventory $13.9M $12.5M $16.7M $18.9M $23M
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.7M $4.3M $1.9M $1.9M $2.8M
Total Current Assets $135M $145.3M $127M $98.1M $88M
 
Property Plant And Equipment $18.1M $54.1M $78.1M $93.7M $104.3M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $1.5M $2.1M $2.9M $3.6M $4.5M
Other Long-Term Assets -- -- -- -- --
Total Assets $154.6M $201.4M $208M $195.4M $196.8M
 
Accounts Payable $8.3M $4.6M $5.9M $9M $11.8M
Accrued Expenses $3.3M $3.8M $6.9M $4.5M $3.2M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- $863K $1.8M $1.3M $1.5M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $20.9M $22.8M $24.3M $23.8M $30.4M
 
Long-Term Debt -- $32M $44.8M $45.7M $46.6M
Capital Leases -- -- -- -- --
Total Liabilities $22.5M $78.2M $95.5M $94.4M $101.2M
 
Common Stock $396K $406K $417K $424K $431K
Other Common Equity Adj -- -- -- -- --
Common Equity $132.2M $123.1M $112.6M $101M $95.7M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $132.2M $123.1M $112.6M $101M $95.7M
 
Total Liabilities and Equity $154.6M $201.4M $208M $195.4M $196.8M
Cash and Short Terms $96.5M $104M $84.1M $48.8M $31M
Total Debt $1.7M $32M $44.8M $45.7M $46.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $60M $46.7M $14.3M $31.1M $18.7M
Short Term Investments $39.1M $45M $38.8M $1.5M $5.9M
Accounts Receivable, Net $18.8M $18.6M $21.4M $23.3M $24.6M
Inventory $11.9M $15.5M $19.1M $23M $29.4M
Prepaid Expenses $2.5M $2.8M -- -- --
Other Current Assets -- -- $2.6M $2.6M $1.7M
Total Current Assets $140M $135M $102.5M $87.4M $86.3M
 
Property Plant And Equipment $52.2M $72M $89.6M $102.9M $100.5M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $1.8M $2.7M $3.4M $4.3M $5.2M
Other Long-Term Assets -- $339K -- -- --
Total Assets $193.9M $210M $195.5M $194.6M $192M
 
Accounts Payable $3.5M $6.4M -- -- --
Accrued Expenses $3.1M $6.4M -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $2.5M $1.7M $1.5M $1.1M $1.9M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $18.8M $23.4M $23.5M $26.6M $23M
 
Long-Term Debt $31.8M $46.2M $45.5M $46.4M $47.3M
Capital Leases -- -- -- -- --
Total Liabilities $72.2M $94.7M $94.1M $96.8M $92.6M
 
Common Stock $401K $415K $423K $430K $440K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $121.7M $115.3M $101.4M $97.8M $99.4M
 
Total Liabilities and Equity $193.9M $210M $195.5M $194.6M $192M
Cash and Short Terms $99.1M $91.7M $53.1M $32.6M $24.5M
Total Debt $31.8M $46.2M $45.5M $46.4M $47.3M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$29.1M -$23.8M -$27M -$28.9M -$21.7M
Depreciation & Amoritzation $2.9M $3.5M $4.7M $4.9M $5.6M
Stock-Based Compensation $10.3M $8.5M $10.9M $15.6M $14.4M
Change in Accounts Receivable -$2.1M -$635K -$499K -$4.6M -$2.7M
Change in Inventories -$3.8M -$910K -$7.5M -$3.7M -$6.1M
Cash From Operations -$19.9M -$9.6M -$13.4M -$16.1M -$5.7M
 
Capital Expenditures $5.2M $22.6M $28.4M $21.3M $14.9M
Cash Acquisitions -- -- -- -- --
Cash From Investing $27.3M -$17M -$23.6M -$3.2M $19.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $29K $42.8M $15M -- --
Long-Term Debt Repaid -- -$7.8M -$15K -$12K -$10K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$1.3M -- -- --
Cash From Financing $4M $40.5M $20.5M $1.8M $2M
 
Beginning Cash (CF) $30.3M $41.7M $55.6M $39M $21.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $11.4M $13.9M -$16.6M -$17.5M $15.5M
Ending Cash (CF) $41.7M $55.6M $39M $21.5M $37M
 
Levered Free Cash Flow -$25.1M -$32.2M -$41.8M -$37.3M -$20.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$1.5M -$7.1M -$4.3M -$4.1M -$1.9M
Depreciation & Amoritzation $894K $1.2M $1.3M $1.4M $2M
Stock-Based Compensation $2.9M $2.9M $3.8M $4.7M $5M
Change in Accounts Receivable -$4.7M -$306K -$976K -$1.4M $448K
Change in Inventories $424K -$2.4M -$346K -$730K $978K
Cash From Operations $2.6M -$376K -$689K $1.6M $3.9M
 
Capital Expenditures $5.9M $9.6M $4.5M $3.9M $1.1M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$21.1M -$6.8M $3M $6M -$5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$2K -$4K -$8K $5K -$2K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$299K -- -- -- --
Cash From Financing $191K $805K $215K $5K $572K
 
Beginning Cash (CF) $85.9M $59.4M $18.1M $29.5M $25.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$18.3M -$6.3M $2.5M $7.6M -$527K
Ending Cash (CF) $67.6M $53.1M $20.6M $37.1M $24.7M
 
Levered Free Cash Flow -$3.3M -$9.9M -$5.2M -$2.3M $2.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$24.8M -$27.7M -$28.8M -$23.2M -$14.3M
Depreciation & Amoritzation $3.2M $4.7M $4.8M $4.9M $7.8M
Stock-Based Compensation $8.6M $12.2M $12.9M $17.2M $14.2M
Change in Accounts Receivable -$3.9M $261K -$3.4M -$1.7M -$2M
Change in Inventories -$2.3M -$6.5M -$5.5M -$4M -$8.3M
Cash From Operations -$15.8M -$9.1M -$18.9M -$4.1M -$4.4M
 
Capital Expenditures $20.5M $24.5M $21.7M $19.9M $5.5M
Cash Acquisitions -- -- -- -- --
Cash From Investing $16M -$29.4M -$15.6M $18.3M -$9.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$7.8M -$16K -$12K -$10K -$9K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $36.9M $23.9M $2M $2.3M $1.7M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $37.1M -$14.5M -$32.5M $16.5M -$12.4M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$36.2M -$33.5M -$40.7M -$24.1M -$9.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$17.8M -$21.7M -$23.5M -$17.8M -$10.4M
Depreciation & Amoritzation $2.4M $3.6M $3.7M $3.7M $5.9M
Stock-Based Compensation $5.7M $9.4M $11.4M $13.1M $12.8M
Change in Accounts Receivable -$1.7M -$804K -$3.7M -$766K -$85K
Change in Inventories -$176K -$5.8M -$3.8M -$4.1M -$6.3M
Cash From Operations -$12.5M -$11.9M -$17.4M -$5.5M -$4.2M
 
Capital Expenditures $19.3M $21.2M $14.5M $13.1M $3.7M
Cash Acquisitions -- -- -- -- --
Cash From Investing $2.4M -$10.1M -$2M $19.5M -$9.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $42.8M $15M -- -- --
Long-Term Debt Repaid -$7.8M -$12K -$9K -$7K -$6K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$1.3M -- -- -- --
Cash From Financing $36M $19.4M $981K $1.5M $1.3M
 
Beginning Cash (CF) $169.5M $161.2M $77.9M $65M $83.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $25.9M -$2.5M -$18.4M $15.6M -$12.4M
Ending Cash (CF) $195.4M $158.7M $59.5M $80.5M $71.6M
 
Levered Free Cash Flow -$31.8M -$33.1M -$31.9M -$18.6M -$7.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock